Literature DB >> 27542840

Extended-spectrum β-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre.

Lisa Jacmel1, Sandra Timsit1, Agnès Ferroni2, Clémentine Auregan1, François Angoulvant1, Gérard Chéron1.   

Abstract

AIM: The last decade has seen a significant increase in extended-spectrum β-lactamase (ESBL) secreting organisms responsible for paediatric urinary tract infections (UTIs), particularly in community-acquired infections. These expose patients to the risks of antibiotic treatment failure and renal scarring. This prospective study examined the prevalence and risk factors of febrile ESBL UTIs and their treatment in the paediatric emergency department of a university hospital.
METHODS: In this prospective observational study, all children from 0 to 16 years of age with febrile UTIs were included from May 2012 to April 2013. Cases with and without ESBL involvement were compared.
RESULTS: Of the 474 diagnosed febrile UTIs, 22 (4.6%) with a 95% confidence interval (95% CI) of 2.9-6.9 were due to an ESBL-producing organism. Escherichia coli was found in 85% of cases. Significant odds ratios (OR) for ESBL urinary tract infections were prior hospitalisation (OR 4.1, 95% CI 1.6-10.8), urinary tract abnormalities (OR 3.9, 95% CI 1.5-10.2) and previous antibiotic treatment (OR 3.1, 95% CI 1.2-8.8). All ESBL urinary tract infections had positive outcomes.
CONCLUSION: The prevalence of febrile ESBL urinary tract infections was less than 5% in a paediatric emergency department. This low rate was not high enough to justify changing our guidelines. ©2016 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Escherichia colizzm321990; Beta-lactamase; Emergency department; Extended-spectrum β-lactamase; Urinary tract infections

Mesh:

Substances:

Year:  2016        PMID: 27542840     DOI: 10.1111/apa.13546

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  2 in total

1.  Prospective Cohort Study Investigating the Safety and Efficacy of Ambulatory Treatment With Oral Cefuroxime-Axetil in Febrile Children With Urinary Tract Infection.

Authors:  Elise Hennaut; Hong P Duong; Benedetta Chiodini; Brigitte Adams; Ksenija Lolin; Sophie Blumental; Karl M Wissing; Khalid Ismaili
Journal:  Front Pediatr       Date:  2018-08-31       Impact factor: 3.418

2.  From Pathophysiological Hypotheses to Case-Control Study Design: Resistance from Antibiotic Exposure in Community-Onset Infections.

Authors:  Salam Abbara; Didier Guillemot; Christian Brun-Buisson; Laurence Watier
Journal:  Antibiotics (Basel)       Date:  2022-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.